The most common type 2 diabetes drug needs the action of a cellular-stress-response protein to make effect (IMAGE)

University of Barcelona

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.